Peritoneal dialysis patients - the forgotten group in the coronavirus pandemic
Affiliation
University Hospitals Birmingham NHS Foundation TrustPublication date
2021-09-10Subject
Patients. Primary care. Medical profession. Forensic medicinePublic health. Health statistics. Occupational health. Health education
Nephrology/Renal medicine
Health services. Management
Metadata
Show full item recordAbstract
While all patients with chronic disease have undoubtedly been affected by the ongoing SARS-CoV-2 (COVID-19) pandemic, individuals with end-stage renal failure have suffered significant excess morbidity and mortality. Patients on haemodialysis have received extensive research and media attention into their vulnerability to the disease; however, those receiving peritoneal dialysis (PD) have been much less visible. We surveyed a selection of patients from a cohort receiving PD at a tertiary renal unit in Birmingham, UK. We devised a questionnaire looking at patients' experience of shielding, accessing both dialysis and general medical care during the pandemic, and their thoughts about the pandemic and the future. Concerning findings were apparent from this. Attending hospital was the most commonly cited reason for being unable to shield, and multiple patients experienced difficulties accessing care while unwell during this period. Worryingly, 58% of respondents indicated that they feel negatively, or feel ambivalent, about the future. Patients receiving PD have suffered significantly during the COVID-19 pandemic and face ongoing difficulties and risks while accessing medical care. It is vital that this cohort is not forgotten in the planning of renal services during the pandemic, and that special attention is paid to both their physical and mental health.Citation
Balson L, Baharani J. Peritoneal dialysis patients - the forgotten group in the coronavirus pandemic. Clin Med (Lond). 2021 Sep;21(5):e556-e558. doi: 10.7861/clinmed.2021-0259.Type
ArticlePMID
34507945Journal
Clinical MedicinePublisher
Elsevierae974a485f413a2113503eed53cd6c53
10.7861/clinmed.2021-0259
Scopus Count
Collections
Related items
Showing items related by title, author, creator and subject.
-
Role of the Guidelines Evidence Specialist in the streamlining of Guidelines at a large acute NHS TrustHeer, Mandeep; Heer, Mandeep; Heer, Mandeep; CEBIS; CEBIS (University Hospitals Coventry and Warwickshire NHS Trust, 2023-11)Role of the Guidelines Evidence Specialist in the streamlining of Guidelines at a large acute NHS Trust
-
Faculty development: clinical dermatology for medical secretaries and administrative staffAgrawal, Rishi; Browne, Rachel; Baldwin, Nicola; Scott, H.; Tso, Simon; Agrawal, R.; Browne, R.; Baldwin, N.; Scott, H.; Tso, S.; et al. (Oxford University Press, 2020-06)A study investigating the potential benefits of specialty-specific clinical inductions for medical secretaries and administrative staff.
-
Mapping inpatient care pathways for patients with COPD: an observational study using routinely collected electronic hospital record data.Evison, Felicity; Cooper, Rachel; Gallier, Suzy; Missier, Paolo; Sayer, Avan A; Sapey, Elizabeth; Witham, Miles D; Evison, Felicity; Gallier, Suzy; Research and Development; et al. (European Respiratory Society, 2023-10-16)Introduction: Respiratory specialist ward care is associated with better outcomes for patients with COPD exacerbations. We assessed patient pathways and associated factors for people admitted to hospital with COPD exacerbations. Methods: We analysed routinely collected electronic health data for patients admitted with COPD exacerbation in 2018 to Queen Elizabeth Hospital, Birmingham, UK. We extracted data on demographics, deprivation index, Elixhauser comorbidities, ward moves, length of stay, and in-hospital and 1-year mortality. We compared care pathways with recommended care pathways (transition from initial assessment area to respiratory wards or discharge). We used Markov state transition models to derive probabilities of following recommended pathways for patient subgroups. Results: Of 42 555 patients with unplanned admissions during 2018, 571 patients were admitted at least once with an exacerbation of COPD. The mean±sd age was 51±11 years; 313 (55%) were women, 337 (59%) lived in the most deprived neighbourhoods and 45 (9%) were from non-white ethnic backgrounds. 428 (75.0%) had ≥4 comorbidities. Age >70 years was associated with higher in-hospital and 1-year mortality, more places of care (wards) and longer length of stay; having ≥4 comorbidities was associated with higher mortality and longer length of stay. Older age was associated with a significantly lower probability of following a recommended pathway (>70 years: 0.514, 95% CI 0.458-0.571; ≤70 years: 0.636, 95% CI 0.572-0.696; p=0.004). Conclusions: Only older age was associated with a lower chance of following recommended hospital pathways of care. Such analyses could help refine appropriate care pathways for patients with COPD exacerbations.